Answers are grounded in this paper and cite their sources.
Background.Currently, mutations inrpoB,KatG, andrrsgenes andinhApromoter were considered to be involved in conferring resistance to rifampicin, isoniazid, and streptomycin inMycobacterium tuberculosis(MTB).Objective.The aims of this study were to detect the prevalence of first-line tuberculosis (TB) drug resistance among a group of previously treated and newly detected TB patients, to determine the association between prevalence of multidrug resistance (MDR) and demographic information (age and sex), to explain genes correlated with MDRMycobacterium tuberculosis, and to characterize MTB via 16S ribosomal RNA (16S rRNA) analysis.Methods.A hundred MTB isolates from Sudanese pulmonary TB patients were included in the study. The proportional method of drug susceptibility test was carried out on Löwenstein-Jensen media. Multiplex PCR ofrpoBandKatGgenes andinhApromoter was conducted; thenrrsgenes were amplified by conventional PCR and were sequenced. The sequences of the PCR product were compared with knownrrsgene sequences in the GenBank database by multiple sequence alignment tools.Result.The prevalence of MDR was 14.7% among old cases and 5.3% among newly diagnosed cases.Conclusion.Mutations inrrscould be considered as a diagnostic marker.
No takes yet. Share an insight, caveat, or question.
Sabeel et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: